Abstract
Accumulation of beta-amyloid (Abeta), produced by the proteolytic cleavage of amyloid precursor protein (APP) by beta- and gamma-secretase, is widely believed to be associated with Alzheimer's disease (AD). Research around the high-throughput screening hit (S)-4-chlorophenylsulfonyl isoleucinol led to the identification of the Notch-1-sparing (9.5-fold) gamma-secretase inhibitor (S)-N-(5-chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol 7.b.2 (Abeta(40/42) EC(50)=28 nM), which is efficacious in reduction of Abeta production in vivo.
MeSH terms
-
Alcohols
-
Alzheimer Disease / drug therapy*
-
Amyloid Precursor Protein Secretases / antagonists & inhibitors*
-
Amyloid Precursor Protein Secretases / metabolism
-
Amyloid beta-Protein Precursor / chemistry
-
Animals
-
Drug Design
-
Humans
-
Isoleucine / analogs & derivatives*
-
Isoleucine / chemistry
-
Models, Chemical
-
Propanolamines / chemistry
-
Receptor, Notch1 / metabolism*
-
Sulfonamides / chemistry
Substances
-
(S)-4-chlorophenylsulfonyl isoleucinol
-
Alcohols
-
Amyloid beta-Protein Precursor
-
Propanolamines
-
Receptor, Notch1
-
Sulfonamides
-
Isoleucine
-
isoleucinol
-
2-aminopropanol
-
Amyloid Precursor Protein Secretases